Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **right ventricular outflow tract** (RVOT) is the muscular channel extending from the main cavity of the right ventricle to the pulmonary valve and artery, serving as the exit pathway for blood from the right ventricle into the pulmonary circulation. The RVOT has complex three-dimensional anatomy, with a distinctive fiber arrangement and is a critical site in congenital heart disease surgeries (such as repair of tetralogy of Fallot) and electrophysiological disease (site of origin for many idiopathic ventricular arrhythmias as well as Brugada syndrome). RVOT pathology—including post-surgical changes—can lead to hemodynamic compromise, arrhythmogenesis, and long-term right ventricular dysfunction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Right ventricular outflow tract (RVOT).